Gilead Sciences, Inc. (NASDAQ:GILD) will release earnings results for the second quarter, after the closing bell on Thursday, Aug. 7.
Analysts expect the health care company to report quarterly earnings at $1.96 per share, down from $2.01 per share in the year-ago period. Gilead Sciences projects to report quarterly revenue of $6.96 billion, compared to $6.95 billion a year earlier, according to data from Benzinga Pro.
On July 25, Needham analyst Joseph Stringer upgraded Gilead Sciences from Hold to Buy and announced a $133 price target.
With the recent buzz around Gilead Sciences, some investors may be eyeing potential gains from the company’s dividends too. As of now, Gilead Sciences offers an annual dividend yield of 2.87%, which is a quarterly dividend amount of 79 cents …